Investigating intra‐tumoural heterogeneity and microenvironment diversity in primary cardiac angiosarcoma through single‐cell RNA sequencing

Insights into the heterogeneity and transcriptional patterns of sarcoma cells may explain the challenges in treating primary cardiac angiosarcoma (PCAS) using the current therapeutic modalities. Characterization of the immune microenvironment revealed significant immunosuppression mediated by specific myeloid cell populations (SPP1+ and OLR1+ macrophages). Identification of mitochondrial dysfunction in immune cells within the PCAS microenvironment, particularly the notable downregulation of the MTRNR2L12 protein, suggests a new avenue for therapeutic targeting.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Medicine
Published
2024-12-01
DOI
https://doi.org/10.1002/ctm2.70113
Citations
3
Primary Topic
Cardiac tumors and thrombi
Type
article
Field-Weighted Citation Impact
1.21

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Investigating intra‐tumoural heterogeneity and microenvironment diversity in primary cardiac angiosarcoma through single‐cell RNA sequencing

Haoyang Li, Jin‐Ling Huo, Hongfei Xu, Hongda Ding et al.
3 citations
Clinical and Translational Medicine
Cardiac tumors and thrombi
1.21
article

Investigating intra‐tumoural heterogeneity and microenvironment diversity in primary cardiac angiosarcoma through single‐cell RNA sequencing

Haoyang Li, Jin‐Ling Huo, Hongfei Xu, Hongda Ding, Fengpu He, Yiming Ni, Firyuza Husanova, Weidong Li, Miao Chen, Yaqi Ma, Xiao Tian, Wenting Zhao, Zhen Wang, Liang Ma
article en
3 citations

Abstract

Insights into the heterogeneity and transcriptional patterns of sarcoma cells may explain the challenges in treating primary cardiac angiosarcoma (PCAS) using the current therapeutic modalities. Characterization of the immune microenvironment revealed significant immunosuppression mediated by specific myeloid cell populations (SPP1+ and OLR1+ macrophages). Identification of mitochondrial dysfunction in immune cells within the PCAS microenvironment, particularly the notable downregulation of the MTRNR2L12 protein, suggests a new avenue for therapeutic targeting.

Clinical and Translational MedicineVol. 14(12)
First Affiliated Hospital Zhejiang University (CN), China Medical University (CN)
National Natural Science Foundation of China
No poverty
Openalex Percentile: Top 17%
Cardiac tumors and thrombi
1.21
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.